Phenotypic protein profiling of different B cell sub-populations using antibody CD-microarrays

Cancer Letters

Volumn 265, Issue 1, 2008, Pages 98-106

  Ellmark, P ^a   Hogerkorp C M ^a   Ek, S ^a   Belov, L ^b   Berglund, M ^c   Rosenquist, R ^d   Christopherson, R I ^b   Borrebaeck, C A K ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UPPSALA UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Antibody microarrays; B cell sub populations; CD antigens; DNA microarrays; Lymphoma

Indexed keywords

CD ANTIGEN; DNA; MEMBRANE ANTIGEN; MESSENGER RNA;

ANTIBODY CD MICROARRAY; ARTICLE; B LYMPHOCYTE SUBPOPULATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE SUBPOPULATION; LYMPHOMA; MEMORY CELL; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ANTIBODIES; ANTIGENS, CD; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; GENE EXPRESSION PROFILING; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE SUBSETS; LYMPHOMA, B-CELL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; PROTEIN ARRAY ANALYSIS; RECEPTORS, ANTIGEN, B-CELL;

EID: 43449096332     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.02.006     Document Type: Article

References (33)

1. Rhodes D.R., and Chinnaiyan A.M. Integrative analysis of the cancer transcriptome. Nat. Genet. 37 Suppl. (2005) S31-S37
2. Ek S., Andreasson U., Hober S., Kampf C., Ponten F., Uhlen M., Merz H., and Borrebaeck C.A. From gene expression analysis to tissue microarrays: a rational approach to identify therapeutic and diagnostic targets in lymphoid malignancies. Mol. Cell. Proteomics 5 (2006) 1072-1081
3. Delahunty C., and Yates III J.R. Protein identification using 2D-LC-MS/MS. Methods 35 (2005) 248-255
4. Aguilar-Mahecha A., Hassan S., Ferrario C., and Basik M. Microarrays as validation strategies in clinical samples: tissue and protein microarrays. OMICS 10 (2006) 311-326
5. Borrebaeck C.A. Antibody microarray-based oncoproteomics. Expert Opin. Biol. Ther. 6 (2006) 833-838
6. Haab B.B. Antibody arrays in cancer research. Mol. Cell. Proteomics 4 (2005) 377-383
7. Wingren C., and Borrebaeck C.A. Antibody microarrays: current status and key technological advances. OMICS 10 (2006) 411-427
8. Wingren C., and Borrebaeck C.A. High-throughput proteomics using antibody microarrays - an update. Expert Rev. Mol. Diagn. 7 (2007) 673-686
9. Woolfson A., Ellmark P., Chrisp J.S., Scott M.A., and Christopherson R.I. The application of CD antigen proteomics to pharmacogenomics. Pharmacogenomics 7 (2006) 759-771
10. Belov L., de la Vega O., dos Remedios C.G., Mulligan S.P., and Christopherson R.I. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Cancer Res. 61 (2001) 4483-4489
11. Belov L., Huang P., Barber N., Mulligan S.P., and Christopherson R.I. Identification of repertoires of surface antigens on leukemias using an antibody microarray. Proteomics 3 (2003) 2147-2154
12. Ellmark P., Belov L., Huang P., Lee C.S., Solomon M.J., Morgan D.K., and Christopherson R.I. Multiplex detection of surface molecules on colorectal cancers. Proteomics 6 (2006) 1791-1802
13. Belov L., Mulligan S.P., Barber N., Woolfson A., Scott M., Stoner K., Chrisp J.S., Sewell W.A., Bradstock K.F., Bendall L., Pascovici D.S., Thomas M., Erber W., Huang P., Sartor M., Young G.A., Wiley J.S., Juneja S., Wierda W.G., Green A.R., Keating M.J., and Christopherson R.I. Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray. Br. J. Haematol. 135 (2006) 184-197
14. Pascual V., Liu Y.J., Magalski A., de Bouteiller O., Banchereau J., and Capra J.D. Analysis of somatic mutation in five B cell subsets of human tonsil. J. Exp. Med. 180 (1994) 329-339
15. - B cell population represents a heterogeneous subset of cells comprising centroblasts, centrocytes, and plasmablasts, prompting phenotypical revision. J. Immunol. 177 (2006) 4341-4349
16. Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat. Rev. Cancer 5 (2005) 251-262
17. Pascual V., Liu Y.J., and Banchereau J. Normal human B cell sub-populations and their malignant counterparts. Baillieres Clin. Haematol. 10 (1997) 525-538
18. Berglund M., Thunberg U., Amini R.M., Book M., Roos G., Erlanson M., Linderoth J., Dictor M., Jerkeman M., Cavallin-Stahl E., Sundstrom C., Rehn-Eriksson S., Backlin C., Hagberg H., Rosenquist R., and Enblad G. Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis. Mod. Pathol. 18 (2005) 1113-1120
19. Ek S., Högerkorp C.M., Dictor M., Ehinger M., and Borrebaeck C.A. Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells. Cancer Res. 62 (2002) 4398-4405
20. C.M. Högerkorp, C.A. Borrebaeck, The genetic programs of subsets of GC founder B cells and sub-epithelial B cells support their role as extrafollicular proliferating plasma blasts (submitted for publication).
21. Stacchini A., Chiarle R., Antinoro V., Demurtas A., Novero D., and Palestro G. Expression of the CD31 antigen in normal B-cells and non Hodgkin's lymphomas. J. Biol. Regul. Homeost. Agents 17 (2003) 308-315
22. Pittner B.T., Shanafelt T.D., Kay N.E., and Jelinek D.F. CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation. Leukemia 19 (2005) 2264-2272
23. Zucchetto A., Sonego P., Degan M., Bomben R., Dal Bo M., Russo S., Attadia V., Rupolo M., Buccisano F., Steffan A., Del Poeta G., Pucillo C., Colombatti A., Campanini R., and Gattei V. Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): identification of markers with prognostic relevance. J. Immunol. Methods 305 (2005) 20-32
24. Norden B., Broberg P., Lindberg C., and Plymoth A. Analysis and understanding of high-dimensionality data by means of multivariate data analysis. Chem. Biodivers 2 (2005) 1487-1494
25. Ray S., Craig F.E., and Swerdlow S.H. Abnormal patterns of antigenic expression in follicular lymphoma: a flow cytometric study. Am. J. Clin. Pathol. 124 (2005) 576-583
26. Alizadeh A.A., Eisen M.B., Davis R.E., Ma C., Lossos I.S., Rosenwald A., Boldrick J.C., Sabet H., Tran T., Yu X., Powell J.I., Yang L., Marti G.E., Moore T., Hudson Jr. J., Lu L., Lewis D.B., Tibshirani R., Sherlock G., Chan W.C., Greiner T.C., Weisenburger D.D., Armitage J.O., Warnke R., Levy R., Wilson W., Grever M.R., Byrd J.C., Botstein D., Brown P.O., and Staudt L.M. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 (2000) 503-511
27. Chang K.C., Huang X., Medeiros L.J., and Jones D. Germinal centre-like versus undifferentiated stromal immunophenotypes in follicular lymphoma. J. Pathol. 201 (2003) 404-412
28. Strömberg S., Bjorklund M.G., Asplund C., Skollermo A., Persson A., Wester K., Kampf C., Nilsson P., Andersson A.C., Uhlen M., Kononen J., Ponten F., and Asplund A. A high-throughput strategy for protein profiling in cell microarrays using automated image analysis. Proteomics 7 (2007) 2142-2150
29. Chen G., Gharib T.G., Huang C.C., Taylor J.M., Misek D.E., Kardia S.L., Giordano T.J., Iannettoni M.D., Orringer M.B., Hanash S.M., and Beer D.G. Discordant protein and mRNA expression in lung adenocarcinomas. Mol. Cell. Proteomics 1 (2002) 304-313
30. Bartling B., Hofmann H.S., Boettger T., Hansen G., Burdach S., Silber R.E., and Simm A. Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma. Lung Cancer 49 (2005) 145-154
31. Hegde P.S., White I.R., and Debouck C. Interplay of transcriptomics and proteomics. Curr. Opin. Biotechnol. 14 (2003) 647-651
32. Nie L., Wu G., and Zhang W. Correlation of mRNA expression and protein abundance affected by multiple sequence features related to translational efficiency in Desulfovibrio vulgaris: a quantitative analysis. Genetics (2006)
33. Mahnke Y.D., and Roederer M. Optimizing a multicolor immunophenotyping assay. Clin. Lab. Med. 27 (2007) 469-485 v